Retatrutide, by Soma Pharmaceuticals , is attracting increasing attention as a potential method for weight control . This dual-action drug merges the properties of a GLP-1 receptor agonist and a GIP receptor activator , intended to not only promote reduced body fat but also target related metabolic … Read More